Italia markets closed

Bausch Health Companies Inc. (BHC)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
6,22+0,02 (+0,39%)
Al 01:52PM EDT. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente6,20
Aperto6,18
Denaro6,19 x 3200
Lettera6,20 x 3200
Min-Max giorno6,00 - 6,30
Intervallo di 52 settimane4,00 - 29,59
Volume2.740.754
Media Volume7.667.732
Capitalizzazione2,252B
Beta (5 anni mensile)1,35
Rapporto PE (ttm)44,46
EPS (ttm)0,14
Prossima data utili31 ott 2022 - 04 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendo10 nov 2010
Stima target 1A15,18
  • GlobeNewswire

    Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scientific Meeting

    ALPHARETTA, Ga., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that multiple presentations were given at the Retina Society 54th Annual Scientific Meeting which took place September 29 – October 2, 2021 in Chicago, IL. “These presentations demonstrate the targeted and compartmentalized nature

  • GlobeNewswire

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

    NEW YORK, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch or the “Company”) (NYSE: BHC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Bausch and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class ac